Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (605016) - Total Liabilities
Based on the latest financial reports, Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (605016) has total liabilities worth CN¥700.20 Million CNY (≈ $102.46 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 605016 operating cash flow to assess how effectively this company generates cash.
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. - Total Liabilities Trend (2016–2024)
This chart illustrates how Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s total liabilities have evolved over time, based on quarterly financial data. Check financial resilience of Shandong Bailong Chuangyuan Bio-Tech Co. to evaluate the company's liquid asset resilience ratio.
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. Competitors by Total Liabilities
The table below lists competitors of Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Kyland Technology Co Ltd
SHE:300353
|
China | CN¥1.86 Billion |
|
Chengdu ALD Aviation Manufacturing Corp
SHE:300696
|
China | CN¥274.31 Million |
|
Winpak Ltd.
TO:WPK
|
Canada | CA$239.81 Million |
|
TECNOGLASS INC. DL-0001
F:7FH
|
Germany | €547.34 Million |
|
Shanghai Waigaoqiao Free Trade Zone Group Co Ltd A
SHG:600648
|
China | CN¥29.88 Billion |
|
Louis HachEtte Group SA
PA:ALHG
|
France | €9.50 Billion |
|
Sixth Street Specialty Lending Inc
NYSE:TSLX
|
USA | $1.89 Billion |
|
PT Super Bank Indonesia Tbk
JK:SUPA
|
Indonesia | Rp9.55 Trillion |
Liability Composition Analysis (2016–2024)
This chart breaks down Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Shandong Bailong Chuangyuan Bio-Tech Co. stock valuation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.21 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.37 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.27 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. (2016–2024)
The table below shows the annual total liabilities of Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥334.27 Million ≈ $48.91 Million |
+35.69% |
| 2023-12-31 | CN¥246.35 Million ≈ $36.05 Million |
+93.99% |
| 2022-12-31 | CN¥126.99 Million ≈ $18.58 Million |
+60.65% |
| 2021-12-31 | CN¥79.05 Million ≈ $11.57 Million |
-45.45% |
| 2020-12-31 | CN¥144.91 Million ≈ $21.20 Million |
-7.87% |
| 2019-12-31 | CN¥157.28 Million ≈ $23.01 Million |
+45.50% |
| 2018-12-31 | CN¥108.09 Million ≈ $15.82 Million |
-42.92% |
| 2017-12-31 | CN¥189.38 Million ≈ $27.71 Million |
-29.64% |
| 2016-12-31 | CN¥269.14 Million ≈ $39.38 Million |
-- |
About Shandong Bailong Chuangyuan Bio-Tech Co. Ltd.
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. engages in the production and sale of food and feed additives in China and internationally. The company offers dietary fibers, including polydextrose and resistant dextrin; prebiotics, such as fructo-oligosaccharide, isomalto-oligosaccharide, galacto-oligosaccharide, and xylo-oligosaccharide. It also provides starch sugars comprising allulose, maltit… Read more